Molecular dynamics in COPD following diets and environmental stressor: Obesity leverage of health care utilize Omics

Authors

  • Adeeb Fae Department of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla NY.
  • Bandar E Almansouri Department of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla NY.
  • Diane E Heck Department of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla NY.
  • Hong Duck Kim Department of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla NY.

DOI:

https://doi.org/10.30574/gscbps.2021.17.2.0228

Keywords:

COPD, Metabolic disorder, Obesity; Diet, Chronic disorders, Nutrigenomic, Molecular imaging

Abstract

Chronic obstructive pulmonary disease (COPD) represented as inflammatory complication of chronic bronchitis which is characterized by oxidative stress driven phenotypic changes likely enlarged alveoli and increased mucus along with tightened smooth muscle which exaggerate pathological consequences such as breathing problems. The association between COPD and obesity as a metabolic disorder following a variety of environmental stressors include lifestyle change (e.g., diet and e-smoking or marijuana) and air pollution are less likely to be evaluated. People who are suffering with COPD developed extensive suffocation and difficulty breathing, which ultimately leads to fatal conditions in severe cases, for example lung cancer, heart attack, and stroke.

Previous studies showed metabolic disorder like obesity appeared as a risk determinant to COPD like breathing problem or deep vein thrombosis and its genetic modification resulted from abnormality of molecular dynamics turned out key trigger in case of immune alteration and inflammation following exposure of several environmental factors which could be linked with comorbidity in secondary chronic diseases pairing with other metabolic disorders (e.g., diabetes, heart disease, cancer or fatty liver disease). Lifestyle changes along with physical activities and management of the diet is worth to reduce COPD symptomatic firing. However, environmental factors like air pollution or particle matter owing to industrialization and urbanization include a variety of dust within indoor life, certain type of e-smoke also triggers the establishment of emphysema and enhances the progression of COPD aligned with molecular alteration in the lung tissue or interaction between different organs. Prediction and prevention skills as key tools of health management and evaluation in case of COPD remains unclear.

Integrative care includes clinic assessment (e.g., the body mass index, diets, and metabolic profile using survey following physician guidance) could be coupled cellular and topological interaction between obesity and COPD supplemented with advanced functional and genetic variation utilize human genomics study like single nucleotide polymorphism (SNP). To understand the impact of environmental risk better (e.g., air pollution or particle matter) on pathogenesis of disease or onset of the disease underlying the pulmonary system stratified lifestyle, age, metabolic disorders, diets, and medications, we envision exploring risks such as disease barrier and social determinants along with detection tools which may assess molecular dynamics and their alteration following stress might be associated with COPD in the pathogenesis. Environmental stressors (e.g., air pollution, particle matter, food addictive chemicals, and stress) as epigenetic modifiers could attribute to early phase of COPD onset and pathogenesis which reflect the molecular dynamics and redirection of networking pathways depending on gut immunity. Profiling of secondary metabolites is worth to explicate intervention of metabolism cascade owing to alter molecular sensitivity and connectivity. Utilized multi-dimensional omics such as metabolomics, genomics with exome sequencing, and epigenomics, prevention and prediction skills could visualize a new angle of disease diagnostic under the platform of integrative health care and surveillance supporting to patient’s quality of life.

Metrics

Metrics Loading ...

References

Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respiratory research. 2010; 11(1): 122.

Alcázar-Navarrete B, Trigueros JA, Riesco JA, Campuzano A, Pérez J. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study". International journal of chronic obstructive pulmonary disease. 2018; 13: 1115–1124.

Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, Quaderi S, Mandal S, Hurst JR. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PloS one. 2020; 15(5): e0233147.

Billingsley H, Rodriguez-Miguelez P, Del Buono MG, Abbate A, Lavie CJ, Carbone S. Lifestyle Interventions with a Focus on Nutritional Strategies to Increase Cardiorespiratory Fitness in Chronic Obstructive Pulmonary Disease, Heart Failure, Obesity, Sarcopenia, and Frailty. Nutrients. 2019; 11(12): 2849.

Collins PF, Elia M, Stratton RJ. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology (Carlton, Vic.). 2013; 18(4): 616–629.

Dixon AE, Pratley RE, Forgione PM, Kaminsky DA, Whittaker-Leclair LA, Griffes LA, Garudathri J, Raymond D, Poynter ME, Bunn JY, Irvin CG. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. The Journal of allergy and clinical immunology. 2011; 128(3): 508–15.e152.

Eisner MD, Blanc PD, Sidney S, Yelin EH, Lathon PV, Katz PP, Tolstykh I, Ackerson L, Iribarren C. Body composition and functional limitation in COPD. Respiratory research. 2007; 8(1): 7.

Esteban C, Garcia-Gutierrez S, Legarreta MJ, Anton-Ladislao A, Gonzalez N, Lafuente I, COPD group, IRYSS. One-year mortality in COPD after an exacerbation: the effect of physical activity changes during the event. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2016; 13(6): 718-725.

Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. The Cochrane database of systematic reviews. 2012; 12: CD000998.

Finkelstein EA, Khavjou OA, Thompson H, Trogdon JG, Pan L, Sherry B, Dietz W. Obesity and Severe Obesity Forecasts Through 2030. American Journal of Preventive Medicine. 2012; 42(6): 563–570.

Fitzgerald MP, Hennigan K, O’Gorman CS, McCarron L. Obesity, diet and lifestyle in 9-year-old children with parentally reported chronic diseases: findings from the Growing Up in Ireland longitudinal child cohort study. Irish Journal of Medical Science. 2019; 188(1): 29–34.

Franssen FME, O’Donnell DE, Goossens GH, Blaak EE, Schols AMWJ. 2008 Obesity and the lung: 5. Obesity and COPD Thorax. 2019; 63(12): 1110–1117.

GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2018; 392(10159): 1859–1922.

Hanson C, Rutten EP, Wouters EF, Rennard S. Influence of diet and obesity on COPD development and outcomes. International journal of chronic obstructive pulmonary disease. 2014; 9: 723–733.

James BD, Jones AV, Trethewey RE, Evans RA. Obesity and metabolic syndrome in COPD: Is exercise the answer? Chronic respiratory disease. 2018; 15(2): 173–181.

Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest. 2006; 130(3): 827–833.

Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2013; 187(3): 228–237.

Lainscak M, von Haehling S, Doehner W, Sarc I, Jeric T, Ziherl K, Kosnik M, Anker SD, Suskovic S. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. Journal of cachexia, sarcopenia and muscle. 2011; 2(2): 81–86.

Mafort TT, Rufino R, Costa CH, Lopes AJ. Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function. Multidisciplinary respiratory medicine. 2016; 11: 28.

McDonald VM, Gibson PG, Scott HA, Baines PJ, Hensley MJ, Pretto JJ, Wood LG. Should we treat obesity in COPD? The effects of diet and resistance exercise training. Respirology (Carlton, Vic.). 2016; 21(5): 875–882.

McLoughlin RF, McDonald VM, Gibson PG, Scott HA, Hensley MJ, MacDonald-Wicks L, Wood LG. The Impact of a Weight Loss Intervention on Diet Quality and Eating Behaviours in People with Obesity and COPD. Nutrients. 2017; 9(10): 1147.

Pellegrino R, Gobbi A, Antonelli A, Torchio R, Gulotta C, Pellegrino GM, Dellacà R, Hyatt RE, Brusasco V. Ventilation heterogeneity in obesity. Journal of applied physiology (Bethesda, Md. 2014; 1985 116(9): 1175–1181.

Pelosi P, Croci M, Ravagnan I, Tredici S, Pedoto A, Lissoni A, Gattinoni L. The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia. Anesthesia and analgesia. 1998; 87(3): 654–660.

Salome CM, Munoz PA, Berend N, Thorpe CW, Schachter LM, King GG. Effect of obesity on breathlessness and airway responsiveness to methacholine in non-asthmatic subjects. International journal of obesity. 2008; (2005); 32(3): 502–509.

Schachter LM, Salome CM, Peat JK, Woolcock AJ. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax. 2001; 56(1): 4–8.

Scoditti E, Massaro M, Garbarino S, Toraldo DM. Role of diet in chronic obstructive pulmonary disease prevention and treatment. Nutrients. 2019; 11(6): 1357.

Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Archives of internal medicine. 2002; 162(13): 1477–1481.

Spelta F, Pasini AF, Cazzoletti L, Ferrari M. Body weight and mortality in COPD: focus on the obesity paradox. Eating and weight disorders-studies on anorexia, bulimia and obesity. 2018; 23(1): 15-22.

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. American Journal of Respiratory and Critical Care Medicine. 1995; 152(5 Pt 2): S77–S121.

Vozoris NT, O'Donnell DE. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Canadian respiratory journal. 2012; 19(3): e18–e24.

Wang C, Zhou J, Wang J, Li S, Fukunaga A, Yodoi J, Tian H. Progress in the mechanism and targeted drug therapy for COPD. Signal transduction and targeted therapy. 2020; 5(1): 248.

Zerah F, Harf A, Perlemuter L, Lorino H, Lorino AM, Atlan G. Effects of obesity on respiratory resistance. Chest. 1993; 103(5): 1470–1476.

Zewari S, Hadi L, van den Elshout F, Dekhuijzen R, Heijdra Y, Vos P. Obesity in COPD: Comorbidities with Practical Consequences? COPD. 2018; 15(5): 464–471.

Gramegna A, Stefano Aliberti S, Marco Confalonierin M, Angelo Corsico A, Luca Richeldi L, Carlo Vancheri C, Francesco Blasi F. Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement. Multidisciplinary Respiratory Medicine. 2018; 13: 39.

Dransfield MT, Wilhelm AM, Flanagan B, Courville C, Tidwell SL, Raju SV, Amit Gaggar A, Chad Steele C, Tang LP, Bo Liu B, Rowe SM. Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD. Chest. 2013; 144(2): 498-506.

Vaughan A, Frazer ZA, Hansbro PM, Yang IA. COPD and the gut-lung axis: the therapeutic potential of fibre. J Thorac Dis. 2019; 11(17): S2173-S2180.

Sorensen GL. Surfactant Protein D in Respiratory and Non-Respiratory Diseases. Front. Med. 5:18.

Suratt BT. Weight Gain and Lung Disease: The Vagary of Body Mass Index and the Dilemma of the Obese Smoker. Am J Respir Crit Care Med. 2014; 189(3): 240–242.

Downloads

Published

2021-11-30

How to Cite

Fae, A. ., Almansouri, B. E. ., Heck, D. E. ., & Kim, H. D. . (2021). Molecular dynamics in COPD following diets and environmental stressor: Obesity leverage of health care utilize Omics. GSC Biological and Pharmaceutical Sciences, 17(2), 131–138. https://doi.org/10.30574/gscbps.2021.17.2.0228

Issue

Section

Review Article